SCHEMBL933155

SCHEMBL933155

SCCC[Si](CCCS)(CCCS)CCCS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8679723 0.82
SCHEMBL4194527 0.82
SCHEMBL16705798 0.79
SCHEMBL80512 0.77
SCHEMBL17063492 0.73
SCHEMBL5606052 0.73
SCHEMBL375323 0.72
SCHEMBL15107772 0.72
SCHEMBL80934 0.70
SCHEMBL4187747 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3883976-A1 IMIDAZOLIUM/THIOL POLYMERIZATION INITIATION SYSTEM DENTSPLY SIRONA Inc. (US) 2021-09-29 EP claimed
CN-113099718-A Initiation system for imidazole/thiol polymerization 登士柏希罗纳有限公司 2021-07-09 CN claimed
US-20200157313-A1 IMIDAZOLIUM/THIOL POLYMERIZATION INITIATION SYSTEM DENTSPLY SIRONA INC. (US) 2020-05-21 US claimed
EP-2451492-A2 COMPOSITIONS FOR TISSUE AUGMENTATION Kuros Biosurgery AG (CH) 2012-05-16 EP claimed
WO-2011004255-A2 COMPOSITIONS FOR TISSUE AUGMENTATION KUROS BIOSURGERY AG (CH) 2011-01-13 WO claimed
US-20100034769-A1 COMPOSITIONS FOR TISSUE AUGMENTATION Kuros Biosurgery, AG 2010-02-11 US claimed
US-7575740-B2 Compositions for tissue augmentation KUROS BIOSURGERY AG (CH) 2009-08-18 US claimed
US-20260102502-A1 CANNABINOID DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY UNIV JOHNS HOPKINS (US) 2026-04-16 US disclosed
US-20250269044-A1 PSMA-TARGETED DENDRIMER NANOPLATFORM FOR CANCER DETECTION AND THERAPY WASHINGTON STATE UNIVERSITY 2025-08-28 US disclosed
EP-4577247-A1 CANNABINOID DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY The Johns Hopkins University (US) 2025-07-02 EP disclosed
EP-4577245-A1 DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY OF PSYCHEDELIC THERAPEUTICS The Johns Hopkins University (US) 2025-07-02 EP disclosed
WO-2025137151-A2 DENDRIMER COMPOSITIONS FOR THE TREATMENT OF ATHEROSCLEROSIS, OBESITY, AND METABOLIC SYNDROMES THE JOHNS HOPKINS UNIVERSITY (US) 2025-06-26 WO disclosed
EP-4504268-A1 DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY OF THERAPEUTICS TO NEURONS The Johns Hopkins University (US) 2025-02-12 EP disclosed
EP-1494730-B1 COMPOSITION FOR HARD TISSUE AUGMENTATION KUROS BIOSURGERY AG (CH) 2012-01-18 EP disclosed
WO-2011004255-A2 COMPOSITIONS FOR TISSUE AUGMENTATION KUROS BIOSURGERY AG (CH) 2011-01-13 WO disclosed
US-20100034769-A1 COMPOSITIONS FOR TISSUE AUGMENTATION Kuros Biosurgery, AG 2010-02-11 US disclosed
US-7575740-B2 Compositions for tissue augmentation KUROS BIOSURGERY AG (CH) 2009-08-18 US disclosed
EP-1494730-A1 COMPOSITION FOR HARD TISSUE AUGMENTATION Kuros Biosurgery AG (CH) 2005-01-12 EP disclosed
US-20030232944-A1 Compositions for tissue augmentation KUROS BIOSURGERY AG 2003-12-18 US disclosed
WO-2003080144-A1 COMPOSITION FOR HARD TISSUE AUGMENTATION KUROS BIOSURGERY AG (CH) 2003-10-02 WO disclosed